Aroa Biosurgery hopes for sales boost after study finds high healing rates

Aroa Biosurgery hopes for sales boost after study finds high healing rates
Aroa founder Brian Ward says the largest study to date of its tissue repair products bodes well for the firm. (Image: Aroa Biosurgery)
Rebecca Stevenson
Aroa Biosurgery founder Brian Ward says a new large study proving the efficacy and cost saving of its tissue repair products should help to convince conservative surgeons to use them. In late December Australian Securities Exchange (ASX) listed Aroa announced a peer-reviewed study of 120 inpatients for two of its treatments, Myriad Matrix and Myriad Morcells, in lower limb reconstructions. The study, which was published in a plastic and reconstructive surgery journal in December, found one application of Myriad achieved tissue coverag...

More Markets

NZ sharemarket ends week down 0.8%
Markets Market Close

NZ sharemarket ends week down 0.8%

The S&P/NZX 50 Index closed at 13,024.7, down 35.38 points or 0.27%.

Graham Skellern 24 Jan 2025
Being AI vs Clare Capital: $150k settlement reached
Markets

Being AI vs Clare Capital: $150k settlement reached

Being AI filed defamation proceedings against Clare Capital and its directors in April.

John Anthony 24 Jan 2025
Akaroa King Salmon boss steps down after 23 years
Primary Sector

Akaroa King Salmon boss steps down after 23 years

Scotsman Stewart Hawthorn takes over from Duncan Bates as Akaroa King Salmon CEO.

John Anthony 24 Jan 2025
Blair Turnbull named CEO of Milford Asset Management
Markets

Blair Turnbull named CEO of Milford Asset Management

Blair Turnbull is set to take the helm as chief executive of Milford Asset Management from March 12.Turnbull, currently CEO of Tower, replaces Mark Ryland. “As we welcome Blair to Milford, we extend our appreciation to Mark Ryland, who will step down as CEO on Blair’s commencemen...

Staff reporters 24 Jan 2025